A company. Institutions are adding.
Facts from SEC filings, not a recommendation.
From SOPH's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.
Price chart by TradingView.
50 is neutral. Buying by more insiders, top executives and bigger stakes raises it. Selling lowers it; pre-planned sales count less.
SEC filings of any kind. 50 means a normal week.
Institutions added 51.5% to their holdings. 43 bought, 20 sold. 4 quarters of net buying in a row.
| Insider | Trade | Shares | Avg price | Value | Owns after | Date |
|---|---|---|---|---|---|---|
Zhenyu XuChief Scientific Officer | Sell | 4K | $7.18 | $29K | 541K | Oct 13Filing ↗ |
| ||||||
Philippe MenuChief Medical Officer | Sell | 5K | $7.26 | $36K | 196K | Oct 12Filing ↗ |
| ||||||
Jurgi CamblongExecutive Chairman | Sell | 9K | $7.26 | $62K | 3M | Oct 12Filing ↗ |
| ||||||
Well Daan VanChief Legal Officer | Sell | 6K | $8.12 | $50K | 333K | Oct 5Filing ↗ |
| ||||||
Manuela ValenteChief People Officer | Sell | 4K | $8.13 | $34K | 206K | Oct 5Filing ↗ |
| ||||||
Abhimanyu VermaChief Technology Officer | Sell | 5K | $8.12 | $43K | 167K | Oct 5Filing ↗ |
| ||||||
Kevin PuylaertChief Sales Officer | Sell | 216 | $8.04 | $2K | 148K | Oct 5Filing ↗ |
| ||||||
George CardozaChief Financial Officer | Sell | 2K | $8.10 | $13K | 307K | Oct 5Filing ↗ |
| ||||||
Philippe MenuChief Medical Officer | Sell | 7K | $8.13 | $60K | 201K | Oct 5Filing ↗ |
| ||||||
Jurgi CamblongExecutive Chairman | Sell | 40K | $8.13 | $327K | 3M | Oct 5Filing ↗ |
| ||||||
Zhenyu XuChief Scientific Officer | Sell | 7K | $8.12 | $60K | 545K | Oct 5Filing ↗ |
| ||||||
Ross MukenChief Executive Officer | Sell | 10K | $8.13 | $80K | 660K | Oct 5Filing ↗ |
| ||||||
"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.
8,500 shares at $7.26 · $62K
4,000 shares at $7.18 · $29K
5,000 shares at $7.26 · $36K
9,838 shares at $8.13 · $80K
7,394 shares at $8.12 · $60K
40,172 shares at $8.13 · $327K
Source: SEC EDGAR filings. For informational purposes. Not investment advice.
Report a problem with this page